Health Dictionary Find a Doctor

Anemia with intrinsic hemolysis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Anemia with intrinsic hemolysis from Other Diseases

To review the differential diagnosis of anemia, click here.

Disease Genetics Clinical manifestation Lab findings
History Symptoms Signs Hemolysis Intrinsic/Extrinsic Hb concentration MCV RDW Reticulocytosis Haptoglobin levels Hepcidin Iron studies Specific finding on blood smear
Serum iron Serum Tfr level Transferrin or TIBC Ferritin Transferrin saturation
G6pd deficiency[1]
  • History of using
+ Intrinsic Normochromic Normocytic ↑ ↑ but usually causes resolution within 4-7 days ↓ ↓ Nl to ↑ Nl ↑ ↑ ↑
Pyruvate kinase deficiency[2] + Intrinsic Normochromic Normocytic ↑ ↑ ↓ Nl ↑ Nl Nl ↑ βˆ’
Sickle cell anemia[3] + Intrinsic Normochromic Normocytic ↑ ↑ ↓ Nl or moderately ↑ Nl Nl Nl or moderately ↑ ↓ Nl
Disease Genetics History Symptoms Signs Hemolysis Intrinsic/Extrinsic Hb concentration MCV RDW Reticulocytosis Haptoglobin levels Hepcidin Serum iron Serum Tfr level IBC Ferritin Transferrin saturation Specific finding on blood smear
HbC disease[4]
  • Glutamic acid–to-lysine mutation in Ξ²-globin
+ Intrinsic Normochromic Normocytic ↑ ↑ ↓ Nl Nl Nl Nl ↓ βˆ’
Paroxysmal nocturnal hemoglobinuria[5][6] + Intrinsic Normochromic Normocytic ↑ ↑ ↓ Nl ↓ Nl ↑ ↓ βˆ’ NA
Hereditary spherocytosis[7] + Intrinsic Normochromic Normocytic ↑ ↑ ↓ Nl ↓ Nl ↑ Nl βˆ’
  • Small, round RBCs with less surface area and no central pallor

References

  1. ↑ Luzzatto L, Seneca E (February 2014). “G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications”. Br. J. Haematol. 164 (4): 469–80. doi:10.1111/bjh.12665. PMCΒ 4153881. PMIDΒ 24372186.
  2. ↑ Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B (September 2015). “Erythrocyte pyruvate kinase deficiency: 2015 status report”. Am. J. Hematol. 90 (9): 825–30. doi:10.1002/ajh.24088. PMCΒ 5053227. PMIDΒ 26087744.
  3. ↑ Singh PC, Ballas SK (March 2015). “Emerging drugs for sickle cell anemia”. Expert Opin Emerg Drugs. 20 (1): 47–61. doi:10.1517/14728214.2015.985587. PMIDΒ 25431087.
  4. ↑ Lemonne N, Billaud M, Waltz X, Romana M, Hierso R, Etienne-Julan M, Connes P (2016). “Rheology of red blood cells in patients with HbC disease”. Clin. Hemorheol. Microcirc. 61 (4): 571–7. doi:10.3233/CH-141906. PMIDΒ 25335812.
  5. ↑ Bunyaratvej A, Butthep P (January 1992). “Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes”. J Med Assoc Thai. 75 Suppl 1: 237–42. PMIDΒ 1402472.
  6. ↑ Kahng J, Kim Y, Kim JO, Koh K, Lee JW, Han K (January 2015). “A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data”. Ann Lab Med. 35 (1): 35–40. doi:10.3343/alm.2015.35.1.35. PMCΒ 4272963. PMIDΒ 25553278.
  7. ↑ Da Costa L, Galimand J, Fenneteau O, Mohandas N (July 2013). “Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders”. Blood Rev. 27 (4): 167–78. doi:10.1016/j.blre.2013.04.003. PMIDΒ 23664421.

Β© 2026 MyEClinic – IFTM Institut fΓΌr Telematik in der Medizin GmbH